Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
Conroy, Thierry, Bosset, Jean-François, Etienne, Pierre-Luc, Rio, Emmanuel, François, Éric, Mesgouez-Nebout, Nathalie, Vendrely, Véronique, Artignan, Xavier, Bouché, Olivier, Gargot, Dany, Boige, Valérie, Bonichon-Lamichhane, Nathalie, Louvet, Christophe, Morand, Clotilde, de la Fouchardière, Christelle, Lamfichekh, Najib, Juzyna, Béata, Jouffroy-Zeller, Claire, Rullier, Eric, Marchal, Frédéric, Gourgou, Sophie, Castan, Florence, Borg, Christophe, Borg, Christophe, Etienne, Pierre-Luc, Rio, Emmanuel, Mesgouez-Nebout, Nathalie, François, Éric, Vendrely, Véronique, Conroy, Thierry, Artignan, Xavier, Bouché, Olivier, Gargot, Dany, Boige, Valérie, Bonichon-Lamichhane, Nathalie, Louvet, Christophe, Morand, Clotilde, de la Fouchardière, Christelle, Ronchin, Philippe, Seitz, Jean-François, Corbinais, Stéphane, Maillard, Emmanuel, Noirclerc, Monique, El Hajbi, Farid, Villing, Anne-Laure, Bécouarn, Yves, Foong Fat Lam Kam Sang, Lam, Artru, Pascal, Bachet, Jean-Baptiste, Hocine, Fayçal, Ligeza-Poisson, Catherine, Vautravers, Claire, Ben Abdelghani, Meher, Aparicio, Thomas, Desot, Elise, Marquis, Isabelle
Published in The lancet oncology (01.05.2021)
Published in The lancet oncology (01.05.2021)
Get full text
Journal Article
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
Doebele, Robert C, Drilon, Alexander, Paz-Ares, Luis, Siena, Salvatore, Shaw, Alice T, Farago, Anna F, Blakely, Collin M, Seto, Takashi, Cho, Byung Chul, Tosi, Diego, Besse, Benjamin, Chawla, Sant P, Bazhenova, Lyudmila, Krauss, John C, Chae, Young Kwang, Barve, Minal, Garrido-Laguna, Ignacio, Liu, Stephen V, Conkling, Paul, John, Thomas, Fakih, Marwan, Sigal, Darren, Loong, Herbert H, Buchschacher, Gary L, Garrido, Pilar, Nieva, Jorge, Steuer, Conor, Overbeck, Tobias R, Bowles, Daniel W, Fox, Elizabeth, Riehl, Todd, Chow-Maneval, Edna, Simmons, Brian, Cui, Na, Johnson, Ann, Eng, Susan, Wilson, Timothy R, Demetri, George D
Published in The lancet oncology (01.02.2020)
Published in The lancet oncology (01.02.2020)
Get full text
Journal Article
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Abou-Alfa, Ghassan K, Sahai, Vaibhav, Hollebecque, Antoine, Vaccaro, Gina, Melisi, Davide, Al-Rajabi, Raed, Paulson, Andrew S, Borad, Mitesh J, Gallinson, David, Murphy, Adrian G, Oh, Do-Youn, Dotan, Efrat, Catenacci, Daniel V, Van Cutsem, Eric, Ji, Tao, Lihou, Christine F, Zhen, Huiling, Féliz, Luis, Vogel, Arndt
Published in The lancet oncology (01.05.2020)
Published in The lancet oncology (01.05.2020)
Get full text
Journal Article
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
Diaz, Luis A, Shiu, Kai-Keen, Kim, Tae-Won, Jensen, Benny Vittrup, Jensen, Lars Henrik, Punt, Cornelis, Smith, Denis, Garcia-Carbonero, Rocio, Benavides, Manuel, Gibbs, Peter, de la Fourchardiere, Christelle, Rivera, Fernando, Elez, Elena, Le, Dung T, Yoshino, Takayuki, Zhong, Wen Yan, Fogelman, David, Marinello, Patricia, Andre, Thierry
Published in The lancet oncology (01.05.2022)
Published in The lancet oncology (01.05.2022)
Get full text
Journal Article
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Abou-Alfa, Ghassan K, Macarulla, Teresa, Javle, Milind M, Kelley, Robin K, Lubner, Sam J, Adeva, Jorge, Cleary, James M, Catenacci, Daniel V, Borad, Mitesh J, Bridgewater, John, Harris, William P, Murphy, Adrian G, Oh, Do-Youn, Whisenant, Jonathan, Lowery, Maeve A, Goyal, Lipika, Shroff, Rachna T, El-Khoueiry, Anthony B, Fan, Bin, Wu, Bin, Chamberlain, Christina X, Jiang, Liewen, Gliser, Camelia, Pandya, Shuchi S, Valle, Juan W, Zhu, Andrew X
Published in The lancet oncology (01.06.2020)
Published in The lancet oncology (01.06.2020)
Get full text
Journal Article
Comparison of the accuracy of human readers versus machine-learning algorithms for pigmented skin lesion classification: an open, web-based, international, diagnostic study
Tschandl, Philipp, Codella, Noel, Akay, Bengü Nisa, Argenziano, Giuseppe, Braun, Ralph P, Cabo, Horacio, Gutman, David, Halpern, Allan, Helba, Brian, Hofmann-Wellenhof, Rainer, Lallas, Aimilios, Lapins, Jan, Longo, Caterina, Malvehy, Josep, Marchetti, Michael A, Marghoob, Ashfaq, Menzies, Scott, Oakley, Amanda, Paoli, John, Puig, Susana, Rinner, Christoph, Rosendahl, Cliff, Scope, Alon, Sinz, Christoph, Soyer, H Peter, Thomas, Luc, Zalaudek, Iris, Kittler, Harald
Published in The lancet oncology (01.07.2019)
Published in The lancet oncology (01.07.2019)
Get full text
Journal Article
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
Locke, Frederick L, Ghobadi, Armin, Jacobson, Caron A, Miklos, David B, Lekakis, Lazaros J, Oluwole, Olalekan O, Lin, Yi, Braunschweig, Ira, Hill, Brian T, Timmerman, John M, Deol, Abhinav, Reagan, Patrick M, Stiff, Patrick, Flinn, Ian W, Farooq, Umar, Goy, Andre, McSweeney, Peter A, Munoz, Javier, Siddiqi, Tanya, Chavez, Julio C, Herrera, Alex F, Bartlett, Nancy L, Wiezorek, Jeffrey S, Navale, Lynn, Xue, Allen, Jiang, Yizhou, Bot, Adrian, Rossi, John M, Kim, Jenny J, Go, William Y, Neelapu, Sattva S
Published in The lancet oncology (01.01.2019)
Published in The lancet oncology (01.01.2019)
Get full text
Journal Article
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
Quénet, François, Elias, Dominique, Roca, Lise, Goéré, Diane, Ghouti, Laurent, Pocard, Marc, Facy, Olivier, Arvieux, Catherine, Lorimier, Gérard, Pezet, Denis, Marchal, Frédéric, Loi, Valeria, Meeus, Pierre, Juzyna, Beata, de Forges, Hélène, Paineau, Jacques, Glehen, Olivier, MARIANI, Pascale, BRIGAND, Cécile, BEREDER, Jean-Marc, MSIKA, Simon, PORTIER, Guillaume, RAT, Patrick
Published in The lancet oncology (01.02.2021)
Published in The lancet oncology (01.02.2021)
Get full text
Journal Article
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
Robert, Caroline, Prof, Ribas, Antoni, Prof, Schachter, Jacob, Prof, Arance, Ana, MD, Grob, Jean-Jacques, Prof, Mortier, Laurent, Prof, Daud, Adil, Prof, Carlino, Matteo S, MB, McNeil, Catriona M, MD, Lotem, Michal, Prof, Larkin, James M G, Prof, Lorigan, Paul, Prof, Neyns, Bart, Prof, Blank, Christian U, Prof, Petrella, Teresa M, MD, Hamid, Omid, MD, Su, Shu-Chih, PhD, Krepler, Clemens, MD, Ibrahim, Nageatte, MD, Long, Georgina V, Prof
Published in The lancet oncology (01.09.2019)
Published in The lancet oncology (01.09.2019)
Get full text
Journal Article
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
Arnold, Melina, PhD, Rutherford, Mark J, PhD, Bardot, Aude, MSc, Ferlay, Jacques, ME, Andersson, Therese M-L, PhD, Myklebust, Tor Åge, PhD, Tervonen, Hanna, PhD, Thursfield, Vicky, Grad Dip, Ransom, David, MD, Shack, Lorraine, PhD, Woods, Ryan R, PhD, Turner, Donna, PhD, Leonfellner, Suzanne, BN, Ryan, Susan, CTR, Saint-Jacques, Nathalie, PhD, De, Prithwish, PhD, McClure, Carol, PhD, Ramanakumar, Agnihotram V, PhD, Stuart-Panko, Heather, CHIM, Engholm, Gerda, MSc, Walsh, Paul M, PhD, Jackson, Christopher, FRACP, Vernon, Sally, MMath, Morgan, Eileen, PhD, Gavin, Anna, FFPHM, Morrison, David S, Prof, Huws, Dyfed W, MSc, Porter, Geoff, MD, Butler, John, MRCOG, Bryant, Heather, PhD, Currow, David C, Prof, Hiom, Sara, BSc, Parkin, D Max, DSc, Sasieni, Peter, Prof, Lambert, Paul C, Prof, Møller, Bjørn, PhD, Soerjomataram, Isabelle, PhD, Bray, Freddie, PhD
Published in The lancet oncology (01.11.2019)
Published in The lancet oncology (01.11.2019)
Get full text
Journal Article
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
Kelley, Robin Kate, Rimassa, Lorenza, Cheng, Ann-Lii, Kaseb, Ahmed, Qin, Shukui, Zhu, Andrew X, Chan, Stephen L, Melkadze, Tamar, Sukeepaisarnjaroen, Wattana, Breder, Valery, Verset, Gontran, Gane, Edward, Borbath, Ivan, Rangel, Jose David Gomez, Ryoo, Baek-Yeol, Makharadze, Tamta, Merle, Philippe, Benzaghou, Fawzi, Banerjee, Kamalika, Hazra, Saswati, Fawcett, Jonathan, Yau, Thomas
Published in The lancet oncology (01.08.2022)
Published in The lancet oncology (01.08.2022)
Get full text
Journal Article
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Guckenberger, Matthias, Lievens, Yolande, Bouma, Angelique B, Collette, Laurence, Dekker, Andre, deSouza, Nandita M, Dingemans, Anne-Marie C, Fournier, Beatrice, Hurkmans, Coen, Lecouvet, Frédéric E, Meattini, Icro, Méndez Romero, Alejandra, Ricardi, Umberto, Russell, Nicola S, Schanne, Daniel H, Scorsetti, Marta, Tombal, Bertrand, Verellen, Dirk, Verfaillie, Christine, Ost, Piet
Published in The lancet oncology (01.01.2020)
Published in The lancet oncology (01.01.2020)
Get full text
Journal Article
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Farge, Dominique, MD, Frere, Corinne, MD, Connors, Jean M, MD, Ay, Cihan, MD, Khorana, Alok A, MD, Munoz, Andres, MD, Brenner, Benjamin, MD, Kakkar, Ajay, MBBS, Rafii, Hanadi, MD, Solymoss, Susan, MD, Brilhante, Dialina, MD, Monreal, Manuel, MD, Bounameaux, Henri, MD, Pabinger, Ingrid, MD, Douketis, James, MD
Published in The lancet oncology (01.10.2019)
Published in The lancet oncology (01.10.2019)
Get full text
Journal Article
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
Motzer, Robert J, Rini, Brian I, McDermott, David F, Arén Frontera, Osvaldo, Hammers, Hans J, Carducci, Michael A, Salman, Pamela, Escudier, Bernard, Beuselinck, Benoit, Amin, Asim, Porta, Camillo, George, Saby, Neiman, Victoria, Bracarda, Sergio, Tykodi, Scott S, Barthélémy, Philippe, Leibowitz-Amit, Raya, Plimack, Elizabeth R, Oosting, Sjoukje F, Redman, Bruce, Melichar, Bohuslav, Powles, Thomas, Nathan, Paul, Oudard, Stéphane, Pook, David, Choueiri, Toni K, Donskov, Frede, Grimm, Marc-Oliver, Gurney, Howard, Heng, Daniel Y C, Kollmannsberger, Christian K, Harrison, Michael R, Tomita, Yoshihiko, Duran, Ignacio, Grünwald, Viktor, McHenry, M Brent, Mekan, Sabeen, Tannir, Nizar M
Published in The lancet oncology (01.10.2019)
Published in The lancet oncology (01.10.2019)
Get full text
Journal Article
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study
Tian, Jianbo, Yuan, Xianglin, Xiao, Jun, Zhong, Qiang, Yang, Chunguang, Liu, Bo, Cai, Yimin, Lu, Zequn, Wang, Jing, Wang, Yanan, Liu, Shuanglin, Cheng, Biao, Wang, Jin, Zhang, Ming, Wang, Lu, Niu, Siyuan, Yao, Zhi, Deng, Xiongbo, Zhou, Fan, Wei, Wei, Li, Qinglin, Chen, Xin, Chen, Wenqiong, Yang, Qin, Wu, Shiji, Fan, Jiquan, Shu, Bo, Hu, Zhiquan, Wang, Shaogang, Yang, Xiang-Ping, Liu, Wenhua, Miao, Xiaoping, Wang, Zhihua
Published in The Lancet Oncology (01.07.2020)
Published in The Lancet Oncology (01.07.2020)
Get full text
Journal Article
Web Resource
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Overman, Michael J, McDermott, Ray, Leach, Joseph L, Lonardi, Sara, Lenz, Heinz-Josef, Morse, Michael A, Desai, Jayesh, Hill, Andrew, Axelson, Michael, Moss, Rebecca A, Goldberg, Monica V, Cao, Z Alexander, Ledeine, Jean-Marie, Maglinte, Gregory A, Kopetz, Scott, André, Thierry
Published in The lancet oncology (01.09.2017)
Published in The lancet oncology (01.09.2017)
Get full text
Journal Article
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Salem, Joe-Elie, Manouchehri, Ali, Moey, Melissa, Lebrun-Vignes, Bénédicte, Bastarache, Lisa, Pariente, Antoine, Gobert, Aurélien, Spano, Jean-Philippe, Balko, Justin M, Bonaca, Marc P, Roden, Dan M, Johnson, Douglas B, Moslehi, Javid J
Published in The lancet oncology (01.12.2018)
Published in The lancet oncology (01.12.2018)
Get full text
Journal Article
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study
Rouvière, Olivier, Puech, Philippe, Renard-Penna, Raphaële, Claudon, Michel, Roy, Catherine, Mège-Lechevallier, Florence, Decaussin-Petrucci, Myriam, Dubreuil-Chambardel, Marine, Magaud, Laurent, Remontet, Laurent, Ruffion, Alain, Colombel, Marc, Crouzet, Sébastien, Schott, Anne-Marie, Lemaitre, Laurent, Rabilloud, Muriel, Grenier, Nicolas, Barry Delongchamps, Nicolas, Boutier, Romain, Bratan, Flavie, Brunelle, Serge, Camparo, Philippe, Colin, Pierre, Corréas, Jean-Michel, Cornélis, François, Cornud, François, Cros, Fanny, Descotes, Jean-Luc, Eschwege, Pascal, Fiard, Gaelle, Fendler, Jean-Philippe, Habchi, Hocine, Hallouin, Philippe, Khairoune, Ahmed, Lang, Hervé, Lebras, Yann, Lefèvre, Frédéric, Malavaud, Bernard, Moldovan, Paul Cezar, Mottet, Nicolas, Mozer, Pierre, Nevoux, Pierre, Pagnoux, Gaele, Pasticier, Gilles, Portalez, Daniel, Potiron, Eric, Thammavong, Athivada Soto, Timsit, Marc-Olivier, Viller, Arnault, Walz, Jochen
Published in The lancet oncology (01.01.2019)
Published in The lancet oncology (01.01.2019)
Get full text
Journal Article
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
Mateo, Joaquin, Porta, Nuria, Bianchini, Diletta, McGovern, Ursula, Elliott, Tony, Jones, Robert, Syndikus, Isabel, Ralph, Christy, Jain, Suneil, Varughese, Mohini, Parikh, Omi, Crabb, Simon, Robinson, Angus, McLaren, Duncan, Birtle, Alison, Tanguay, Jacob, Miranda, Susana, Figueiredo, Ines, Seed, George, Bertan, Claudia, Flohr, Penny, Ebbs, Berni, Rescigno, Pasquale, Fowler, Gemma, Ferreira, Ana, Riisnaes, Ruth, Pereira, Rita, Curcean, Andra, Chandler, Robert, Clarke, Matthew, Gurel, Bora, Crespo, Mateus, Nava Rodrigues, Daniel, Sandhu, Shahneen, Espinasse, Aude, Chatfield, Peter, Tunariu, Nina, Yuan, Wei, Hall, Emma, Carreira, Suzanne, de Bono, Johann S
Published in The lancet oncology (01.01.2020)
Published in The lancet oncology (01.01.2020)
Get full text
Journal Article
Digital pathology and artificial intelligence
Niazi, Muhammad Khalid Khan, Parwani, Anil V, Gurcan, Metin N
Published in The lancet oncology (01.05.2019)
Published in The lancet oncology (01.05.2019)
Get full text
Journal Article